Metabolon – Empowering Your Decisions

Having completed over 180 studies to evaluate drug efficacy, predict drug safety, and diagnose and monitor disease, Metabolon is the established leader of production-ready metabolomics services. 

Approach - Metabolon provides a unique global and non-targeted approach to metabolomics so that a broad spectrum of biochemical biomarkers is identified in every sample.  Metabolon’s approach minimizes the risk of missing those results that may be critical to a research program. 

Application - Identifying changes in biochemical small molecule signals is not a sufficient endpoint for effective biomarker discovery--it’s just the beginning.  Using our patented informatics infrastructure, extensive database of named structures, and rigorous statistical analyses we identify and report the biochemical biomarkers that span virtually the entire spectrum of biochemical pathways. 

Intelligence - Making informed decisions about the next steps in drug discovery or diagnostic research can’t be made on biomarker information alone.  At Metabolon, we take biomarker identification to the next level by providing a rigorous analysis describing how the observed biomarker changes effect biochemical processes. 

These unique features combine to produce reports consisting of named biomarkers and extensive analyses of the impacted biochemical and biological processes.  Together, these give scientists the reliable, actionable, and predictive intelligence they need to confidently advance their research programs.